KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amneal Pharmaceuticals (AMRX) Intangibles: 2017-2025

Historic Intangibles for Amneal Pharmaceuticals (AMRX) over the last 8 years, with Sep 2025 value amounting to $587.9 million.

  • Amneal Pharmaceuticals' Intangibles fell 24.64% to $587.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $587.9 million, marking a year-over-year decrease of 24.64%. This contributed to the annual value of $732.4 million for FY2024, which is 17.75% down from last year.
  • As of Q3 2025, Amneal Pharmaceuticals' Intangibles stood at $587.9 million, which was down 9.48% from $649.5 million recorded in Q2 2025.
  • Over the past 5 years, Amneal Pharmaceuticals' Intangibles peaked at $1.3 billion during Q2 2021, and registered a low of $587.9 million during Q3 2025.
  • Over the past 3 years, Amneal Pharmaceuticals' median Intangibles value was $819.9 million (recorded in 2024), while the average stood at $823.8 million.
  • Data for Amneal Pharmaceuticals' Intangibles shows a maximum YoY dropped of 26.26% (in 2021) over the last 5 years.
  • Over the past 5 years, Amneal Pharmaceuticals' Intangibles (Quarterly) stood at $1.2 billion in 2021, then fell by 6.07% to $1.1 billion in 2022, then decreased by 18.76% to $890.4 million in 2023, then dropped by 17.75% to $732.4 million in 2024, then declined by 24.64% to $587.9 million in 2025.
  • Its Intangibles stands at $587.9 million for Q3 2025, versus $649.5 million for Q2 2025 and $689.1 million for Q1 2025.